MedTrace Logo

chronOS Inject in Proximal Tibial Fractures

NCT02056834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-03-03

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to observe the safety, the radiological and clinical outcomes of chronOS Inject after having been used as bone void filler in internal fixation of proximal tibial fractures.

Conditions

  • Closed Proximal Tibial Fracture Schatzker I - VI
  • Closed Proximal Tibial Fracture AO-OTA 41
  • Closed Proximal Tibial Fracture AO-OTA 42

Interventions

DEVICE

chronOS Inject

chronOS Inject is used as bone void filler in internal fixation of proximal tibial fractures

Sponsors & Collaborators

  • Synthes GmbH

    lead INDUSTRY

Principal Investigators

  • Chang-Wug Oh, MD · Kyungpook National University Hospital

  • Kichul Park, MD · Hanyang University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-01
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056834 on ClinicalTrials.gov